量子生物化学 洞察在a1A-腺素受体中的配体识别
Luana Talinne da Costa Gomes1, Katyanna Sales Bezerra2, Elaine Cristina Gavioli1
1Department of Biophysics and Pharmacology, Federal University of Rio Grande Do Norte, Natal 59072-970, Rio Grande do Norte, Brazil.
ACS omega
|March 2, 2026
概括
量子生物化学方法准确地预测了连接物与α-1A腺受体 (α1A-AR) 的结合. 这项研究揭示了关键的分子相互作用,有助于设计针对α1A-AR相关疾病的选择性药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
- 结构生物学 结构生物学
背景情况:
- 了解连接体与α-1A上腺受体 (α1A-AR) 的相互作用,对于开发向疗法至关重要.
- 现有的知识缺乏详细的分子洞察力,了解各种α1A-AR配体的结合机制.
研究的目的:
- 用量子生物化学方法阐明在α1A-AR上对联体识别的分子基础.
- 描述氨基酸残留对诺拉地林,氧米素和坦苏洛辛与α1A-AR结合的能量贡献.
主要方法:
- 采用密度函数理论 (DFT) 结合分子分化与合盖 (MFCC) 方法.
- 对α1A-AR与三种不同的配体进行了详细的能量表征:诺拉丁上腺素,氧甲素和tamsulosin.
主要成果:
- 计算的结合能量准确地重现了实验中的相对亲和关系 (tamsulosin > oxymetazoline > noradrenaline).
- 确定了所有配体共同的关键相互作用残留物 (ASP106,VAL107,PHE288,PHE312).
- 揭示了oxymetazoline和tamsulosin的明显相互作用模式,解释了它们独特的药理学特征和高选择性.
结论:
- 在量子层面上,MFCC-DFT协议可靠地模拟了α1A-AR-连接体相互作用.
- 对联体结合的详细分子洞察力为合理的药物设计提供了基础.
- 这些发现为开发具有提高选择性,有效性和安全性的新型α1A-AR配体提供了宝贵的指导.
相关概念视频
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.8K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.8K
Ligand Binding Sites
15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K
Ligand Binding Sites
9.0K
9.0K
Adrenergic Receptors: ɑ Subtype
3.1K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K
The Two-State Receptor Model
3.3K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.3K
G Protein-coupled Receptors
18.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.4K


